TABLE 2.
Clinical characteristics of the hospitalized study cohort
| Variable | Result fora
: |
P value | |
|---|---|---|---|
| CRE carriers (n = 40) | Hospitalized non-CRE carriers (n = 22) | ||
| GID | 8 (20) | 1 (4.6) | 0.08 |
| Radiotherapy | 3 (7.5) | 2 (9.1) | NS |
| Chemotherapy | 17 (42.5) | 6 (27.3) | 0.16 |
| Diabetes mellitus | 17 (42.5) | 12 (54.6) | NS |
| Culturesb (sputum and/or urine and/or blood) | |||
| Positive | 33 (82.5) | 16 (72.7) | NS |
| Negative | 4 (10) | 5 (22.7) | |
| Missing | 3 (7.5) | 1 (4.5) | |
| Bacteremia | |||
| Positive | 19 (47.5) | 5 (22.7) | 0.03 |
| Negative | 17 (42.5) | 16 (72.7) | |
| Missing | 4 (10) | 1 (4.5) | |
| Treatment with antibioticsc | |||
| Yes | 34 (85.5) | 20 (90.9) | NS |
| No | 2 (5) | 1 (4.5) | |
| NA | 4 (10) | 1 (4.5) | |
| Broad-spectrum antibiotics | |||
| All kinds | |||
| Yes | 27 (67.5) | 17 (77.3) | NS |
| No | 9 (22.5) | 4 (18.2) | |
| NA | 4 (10) | 1 (4.5) | |
| Carbapenem | |||
| Yes | 10 (25) | 3 (13.6) | 0.2 |
| No | 26 (65) | 18 (81.8) | |
| NA | 4 (10) | 1 (4.5) | |
| Narrow-spectrum antibiotics | |||
| Yes | 7 (17.5) | 3 (13.6) | NS |
| No | 29 (72.5) | 18 (81.8) | |
| NA | 4 (10) | 1 (4.5) | |
| Length of stay until recruitment (days) | 10 ± 3d | 11 ± 2 | NS |
a
Length of stay is given as mean ± standard error of the mean; other values are expressed as number (percent) of patients. NA, not available.
b
Bacteremia caused by any bacteria, and not specifically by CRE.
c
All hospitalized participants were receiving antibiotic treatment during the fecal sampling.
d
Calculated with exclusion of one patient, who was hospitalized for 263 days.